Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

msh id	COM:SCHRODINGER
symbol	SDGR
name	Schrödinger, Inc.
homepage url	https://www.schrodinger.com
country	US
sector	Healthcare
industry	Medical - Healthcare Information Services
market	STOCKS
employee count	867
crunchbase url	-
linkedin url	-
founders	-

market cap	1.5B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.2
growth cost of revenue	-0.04
growth depreciation and amortization	0.28
growth ebitda	-0.19
growth ebitda ratio	0.01
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.09
growth gross profit	0.39
growth gross profit ratio	0.16

COM:SCHRODINGER

Schrödinger, Inc.

Last Close

19.17

21/11 20:18

Market Cap

1.50B

Beta: -

Volume Today

594.39K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	394.11M
cost of revenue	394.11M
depreciation and amortization	5.55M
ebitda	-171.9M
ebitda ratio	-0.79
eps	0.57
eps diluted	0.54
operating expenses	317.55M
operating income	-177.45M
operating income ratio	-0.82

accounts receivables	-20.03M
capital expenditure	-13.4M
cash at beginning of period	95.72M
cash at end of period	161.07M
inventory	-
working capital ttm	442.72M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-